Clinical Trial Update: Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old [Phase 2]

View source ↗

Summary

Phase 2 clinical pharmacology study of 35/4 NEXThaler in children aged 5-11 with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• NEXThaler 35/4 (not specified)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED